We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

Plastic surgery trends show growing acceptance of aesthetic procedures as self-care, with over 28.5 million minimally ...

Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed ...

Hummus is creamy, flavorful and packed with nutrition. Learn about its health benefits and easy ways to add more hummus to your diet.

Walking in place and even hopping are types of water aerobic exercises. Here’s a list of workouts for all ages, including ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

Amy Slaton is making a daring career change by starting a solo creative route as an artist, suggesting the end of 1000-lb Sisters after a journey of dramatic weight loss, legal issues, and personal gr ...